- Home
- RIGL vs FTK Comparison
RIGL vs FTK Comparison
Compare RIGL & FTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIGL
- FTK
- Stock Information
- Founded
- RIGL 1996
- FTK 1985
- Country
- RIGL United States
- FTK United States
- Employees
- RIGL N/A
- FTK N/A
- Industry
- RIGL Biotechnology: Pharmaceutical Preparations
- FTK Major Chemicals
- Sector
- RIGL Health Care
- FTK Industrials
- Exchange
- RIGL Nasdaq
- FTK Nasdaq
- Market Cap
- RIGL 335.5M
- FTK 336.2M
- IPO Year
- RIGL 2000
- FTK N/A
- Fundamental
- Price
- RIGL $30.17
- FTK $16.46
- Analyst Decision
- RIGL Buy
- FTK Buy
- Analyst Count
- RIGL 5
- FTK 2
- Target Price
- RIGL $38.20
- FTK $12.00
- AVG Volume (30 Days)
- RIGL 668.8K
- FTK 513.6K
- Earning Date
- RIGL 11-06-2025
- FTK 11-03-2025
- Dividend Yield
- RIGL N/A
- FTK N/A
- EPS Growth
- RIGL N/A
- FTK 82.12
- EPS
- RIGL 5.43
- FTK 0.43
- Revenue
- RIGL $267,921,000.00
- FTK $214,211,000.00
- Revenue This Year
- RIGL $59.93
- FTK $19.47
- Revenue Next Year
- RIGL N/A
- FTK $11.22
- P/E Ratio
- RIGL $5.32
- FTK $41.21
- Revenue Growth
- RIGL 105.62
- FTK 21.72
- 52 Week Low
- RIGL $13.57
- FTK $4.70
- 52 Week High
- RIGL $43.72
- FTK $17.89
- Technical
- Relative Strength Index (RSI)
- RIGL 39.94
- FTK 67.70
- Support Level
- RIGL $27.75
- FTK $15.02
- Resistance Level
- RIGL $29.46
- FTK $17.93
- Average True Range (ATR)
- RIGL 1.49
- FTK 1.10
- MACD
- RIGL -0.41
- FTK 0.39
- Stochastic Oscillator
- RIGL 25.90
- FTK 76.90
About RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.
About FTK Flotek Industries Inc.
Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.